Sterile Basics of Compounding: Contamination Control Strategies, Part 1.

Area of Science:

• Pharmaceutical Compounding
• Sterile Preparations
• Cleanroom Technology

Background:

• Compounded sterile preparations must be sterile to prevent patient harm or death from parenteral administration.
• Effective cleanroom contamination control is essential for protecting final pharmaceutical products and patient safety.
• Failure to maintain sterility in compounded preparations poses significant risks, including life-threatening consequences.

Purpose of the Study:

• To describe a holistic approach to implementing basic cleanroom contamination control strategies in sterile compounding facilities.
• To identify sources of cleanroom contamination and their associated costs and implications.
• To focus on facility controls essential for preventing contaminant ingress and cross-contamination.

Main Methods:

• Review of fundamental cleanroom contamination sources.
• Analysis of the economic and clinical impact of cleanroom contamination.
• Examination of facility-based controls for preventing contamination.

Main Results:

• Identified common sources of contamination within cleanroom environments.
• Highlighted the significant costs and patient safety risks associated with inadequate contamination control.
• Detailed specific facility controls necessary to mitigate contaminant ingress and cross-contamination.

Conclusions:

• Implementing robust facility controls is a foundational step in ensuring the sterility of compounded preparations.
• A multi-faceted approach to cleanroom contamination control is vital for producing safer pharmaceutical compounds.
• This article provides essential strategies for sterile compounding facilities to enhance product safety and patient well-being.